Agios Pharmaceuticals Statistics
NASDAQ: AGIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
27.60-1.16 (-4.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Agios Pharmaceuticals by the numbers
Agios Pharmaceuticals has a market capitalization of $1.65 billion based on 59.81M shares outstanding. With trailing EPS of $-6.31, Agios Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.4% below its 50-day average and 13.4% below its 200-day average.
Average daily trading volume is 1.06M shares, or about $29.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AGIO valuation vs. peer median
| Metric | AGIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.65B | $1.70B | -3% |
| Avg. volume | 1.06M | 709.88K | +49% |
Peer median across 8 companies: BRVE, RARE, ZBIO, KRSA, SDGR, ANIP, TRAX, STOK.
Valuation
- Market cap
- $1.65B
- Price / sales (latest FY)
- 30.55
- EPS (TTM)
- $-6.31
- Shares outstanding
- 59.81M
Price and trading
- Previous close
- 28.76
- Open
- 28.01
- Day range
- 27.43 – 29.14
- 52-week range
- 24.16 – 44.09
- 52-week change
- +9.35%
- Beta
- —
- Volume
- 776.16K
- Average volume
- 1.06M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.65B
- Forward Pe
- -8.64
- Eps
- -6.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.09
- Week52 Low
- 24.16
- Avg Volume
- 1.06M
- Shares Outstanding
- 59.81M
- Ma50
- 32.64
- Ma200
- 31.89
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -37.40%
- Pct From52w Low
- 14.24%